Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,552 across all filing types
Latest filing 2025-03-01 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Please find enclosed copies of the Newspaper publication of Financial Results for the quarter and year ended 31st December 2024, of the Company published on 1st March 2025, in Business ....
Regulatory Filings
2025-03-01 English
Annual Secretarial Compliance Report enclosed
Regulatory Filings
2025-02-28 English
Integrated Filing- Financial
Annual Report Classification · 95% confidence The document is titled 'Integrated Filing (Financial) for the quarter and year ended 31st December 2024' and contains detailed audited standalone financial results, including income statements, balance sheets, and cash flow statements for the year ended December 31, 2024. It also includes notes on accounting policies and audit committee and board approvals. The presence of comprehensive financial data for a full fiscal year, along with audit references and detailed financial statements, indicates this is a full annual financial report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K equivalent). FY 2024
2025-02-28 English
Integrated Filing (Financial) for the quarter and year ended 31st December 2024
Annual Report Classification · 95% confidence The document is titled 'Integrated Filing (Financial) for the quarter and year ended 31st December 2024' and contains detailed audited standalone financial results, including income statements, balance sheets, and cash flow statements for the year ended December 31, 2024. It also includes notes on accounting policies and audit committee and board approvals. The presence of comprehensive financial data for a full fiscal year, along with audit references and detailed financial statements, indicates this is a full annual financial report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2024
2025-02-28 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It details orders received from various tax authorities regarding tax demands and proceedings related to input tax credit for FY 2020-21. The document provides specifics of the orders, their nature, and the impact on the company, which is stated to be immaterial financially or operationally. There are no financial statements, earnings data, or management analysis present. The document is a regulatory disclosure about legal/tax proceedings and compliance, not a full report or financial statement. It fits best under Regulatory Filings (RNS) as it is a compliance disclosure about regulatory orders and does not qualify as an Audit Report, Legal Proceedings Report, or any other specific category.
2025-02-28 English
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a formal disclosure submitted to stock exchanges (BSE and NSE) under Regulation 30 of the SEBI (LODR) Regulations, 2015. It details orders received from various tax authorities regarding tax demands, penalties, and related proceedings. The document does not contain financial statements, management discussion, or detailed financial analysis. It is a regulatory announcement about legal and compliance matters (tax orders and their impact). The document length is 6251 characters, which is sufficient for a detailed regulatory announcement but does not constitute a full report like an Annual Report or Interim Report. There is no indication that this is a report publication announcement or a certification. The content fits best under Regulatory Filings (RNS) as it is a compliance disclosure about legal orders and their impact on the company.
2025-02-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.